Hormonal
Weight loss efficacy from primary care interventions attenuates over time, with an average regain of 0.53 kg per 6 months, even when the intervention continues.
Don't expect your weight loss to stay perfectly static. Even with ongoing treatment, you may regain about 0.5 kg every 6 months. This is normal. To maintain your loss, you likely need to stay on your treatment plan (including medication if used) long-term, rather than treating it as a short-term fix.
In all interventions, efficacy declined with time (reduction in weight loss by 0.53 kg per 6 months, 95% CI: 0.04–1.0 kg).
Why this rating
Derived from the same meta-analysis with heterogeneity, but the trend is statistically significant (p=0.04).
Source
A closer look at weight loss interventions in primary care: a systematic review and meta-analysis
Leigh Perreault et al. · Frontiers in Medicine · 2023
DOI 10.3389/fmed.2023.1204849
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →